Filing Details

Accession Number:
0000791908-13-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-15 18:48:09
Reporting Period:
2013-11-13
Filing Date:
2013-11-15
Accepted Time:
2013-11-15 18:48:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267273 Fred Kurland C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Cfo & Vp Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2013-11-13 22,596 $0.00 34,416 No 4 M Direct
Common Shares Disposition 2013-11-13 12,331 $3.91 22,085 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Restricted Stock Units Disposition 2013-11-13 22,596 $0.00 22,596 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,531 2012-11-13 2015-08-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 17,396 Indirect by 401(k)
Common Shares 5,000 Indirect by Trust
Footnotes
  1. These restricted stock units were granted on October 27, 2011 and are scheduled to vest in substantially equal installments on each of November 13, 2012, November 13, 2013 and November 14, 2014.
  2. Each restricted stock unit represents the right to receive, upon vesting, one share of common stock. This nondiscretionary transaction represents the vesting of restricted stock units as shares of common stock.
  3. Shares sold on the open market to satisfy the maximum amount of taxes that may be required to be withheld in connection with the vesting of the shares in a non-discretionary transaction pursuant to the reporting person's agreement under the Company's equity incentive plan.